Ultra-Widefield Fluorescein Angiography by Oral Administration of Fluorescein

Ultra-Widefield Fluorescein Angiography by Oral Administration of Fluorescein - Oral-UWFA

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012481

Enrollment

Registered

2013-12-04

Start date

2013-07-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic retinopathy, retinal vein occulusion, uveites

Interventions

Those who received oral UWF-FA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Those patients with diabetic retinopathy, retinal vein occlusion and uveites are recruited.

Exclusion criteria

Exclusion criteria: Exclusion criteria are patients who have history of fluorescein allergy, liver function failure, abnormal hypertension, cerebral vascular disorder, pregnant and minority.

Design outcomes

Primary

Measure	Time frame
Existence of side effects and usefulness	—

Countries

Japan

Contacts

Public ContactMasahiko Sugimoto

Mie University, School of Medicine Department of Ophthalmology

Sugimochi@clin.medic.mie-u.ac.jp059-231-5027

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026